Predict your next investment

Venture Capital
tptf.co

See what CB Insights has to offer

Investments

8

Portfolio Exits

1

About Trans-Pacific Technology Fund

The Trans-Pacific Technology Fund is a technology-driven venture capital fund, investing in companies that are shaping the future of global business.

Trans-Pacific Technology Fund Headquarter Location

12F, No.149, Xinyi Rd Sec.3, Da-an District

Taipei,

Taiwan

+886 2 2325 8218

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Trans-Pacific Technology Fund News

INDONESIAN HEALTHCARE STARTUP PRIXA RAISES $3M LED BY MDI AND TPTF

Jun 9, 2021

INDONESIAN HEALTHCARE STARTUP PRIXA RAISES $3M LED BY MDI AND TPTF TECHCRUNCH.COM — Indonesian healthcare startup  Prixa  has raised $3 million led by MDI Ventures and the Trans-Pacific Technology Fund (TPTF), with participation from returning investors including Siloam Hospitals Group. This brings Prixa’s total raised to $4.5 million since it launched in 2019. Co-founder and chief executive officer James Roring M.D., told TechCrunch in an email that the new funding will enable Prixa to scale its platform and customer base. Prixa uses a B2B model, partnering with healthcare payers like insurance providers and corporations. Through its B2B customers, it currently serves about 10 million patients. Prixa currently works with four major insurers and has six additional insurers in its short-term pipeline. It also works with Indonesia’s largest third-party administrators, Roring said, allowing it to reach more policyholders. Prixa’s platform includes a digital health assistant to answer patients’ questions, telemedicine consultations, pharmacy deliveries and on-demand lab diagnostics. Usage increased during the COVID-19 pandemic as more patients sought online consultations for primary care. Other telehealth startups in Indonesia include Halodoc and Alodokter (which is also backed by MDI). Both connect patients directly with healthcare and insurance providers. Roring said Prixa differentiates by focusing on greater cost control for healthcare payers and positioning itself as a digital primary care platform. “By symptomatically managing patients outside of tertiary care facilities and caring for chronic non-communicable diseases online, Prixa is able to effectively reduce the amount of outpatient claims and downstream inpatient cost incurred by healthcare payers,” Roring said. “Additionally, the combination of a growing and robust medical database, as well as proven clinical guidelines, contribute to cost efficiency and service optimization through the standardization of treatment by our healthcare providers.” In a press statement about the funding, Aditia Henri Narendra, MDI Ventures’ general manager of legal and corporate communication, said, “MDI co-led this financing because Prixa has demonstrated its ability to support insurance companies and hospitals in making medical services more accessible and affordable through its AI telemedicine platform.” Source :

Trans-Pacific Technology Fund Investments

8 Investments

Trans-Pacific Technology Fund has made 8 investments. Their latest investment was in Rey Electronic Systems as part of their Seed VC on September 9, 2021.

CBI Logo

Trans-Pacific Technology Fund Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/13/2021

Seed VC

Rey Electronic Systems

$1M

Yes

4

6/4/2021

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

11/25/2020

Series B

Subscribe to see more

Subscribe to see more

10

9/17/2020

Series C

Subscribe to see more

$99M

Subscribe to see more

10

5/20/2019

Series B - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/13/2021

6/4/2021

11/25/2020

9/17/2020

5/20/2019

Round

Seed VC

Seed VC

Series B

Series C

Series B - II

Company

Rey Electronic Systems

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$1M

$99M

$99M

$99M

New?

Yes

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

4

10

10

10

10

Trans-Pacific Technology Fund Portfolio Exits

1 Portfolio Exit

Trans-Pacific Technology Fund has 1 portfolio exit. Their latest portfolio exit was Finch Therapeutics on March 19, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/19/2021

IPO

$99M

3

Date

3/19/2021

Exit

IPO

Companies

Valuation

$99M

Acquirer

Sources

3

Trans-Pacific Technology Fund Team

1 Team Member

Trans-Pacific Technology Fund has 1 team member, including current Managing Partner, Glenn Kline.

Name

Work History

Title

Status

Glenn Kline

Managing Partner

Current

Name

Glenn Kline

Work History

Title

Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.